Gainers
Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
According to data from Benzinga Pro, during Q4, Talis Biomedical's (NASDAQ:TLIS) reported sales totaled $858.00 thousand. Despite a 25.42% increase in earnings, the company posted a loss of $28.65 million.